View in EDS

A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.

Saved in:
Bibliographic Details
Title: A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.
Authors: Truong DD; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona., Kratz A; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona., Park JG; Virginia G. Piper Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona., Barrientos ES; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona., Saini H; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona., Nguyen T; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona., Pockaj B; Department of Surgery, Mayo Clinic, Phoenix, Arizona., Mouneimne G; University of Arizona Cancer Center, Tucson, Arizona., LaBaer J; Virginia G. Piper Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona., Nikkhah M; School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona. mnikkhah@asu.edu.
Source: Cancer research [Cancer Res] 2019 Jun 15; Vol. 79 (12), pp. 3139-3151. Date of Electronic Publication: 2019 Apr 16.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-18-2293